Tore Haslemo

Vitenskapelige publikasjoner

Faraj, Pari; Haslemo, Tore ; Tran, Jenny Phung; Stingl, Julia; Molden, Espen; Hole, Kristine (2024). Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population. British Journal of Clinical Pharmacology.
https://doi.org/10.1111/bcp.16156

Hole, Kristine ; Lorentsen, Silje K; Nordby, Karoline L; Sørum, Ida TG; Molden, Espen; Haslemo, Tore (2024). Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets. European Journal of Clinical Pharmacology.
https://doi.org/10.1007/s00228-024-03655-z

Hole, Kristine ; Gangsø, Sofie; Jensstuen, Åse Tonette; Ormøy, Hanne Holte; Paulsen, Maren; Molden, Espen; Haslemo, Tore (2023). Effect of CYP2D6 genotype on duloxetine serum concentration. Basic & Clinical Pharmacology & Toxicology. Vol. 134.
https://doi.org/10.1111/bcpt.13954

Hole, Kristine ; Haslemo, Tore ; Molden, Espen (2023). Impact of CYP2D6 Genotype on Paroxetine Serum Concentration. 5 s. Therapeutic Drug Monitoring. Vol. 45.
https://doi.org/10.1097/FTD.0000000000001096

Solhaug, Vigdis; Haslemo, Tore ; Kringen, Marianne Kristiansen ; Molden, Espen; Dietrichs, Erik Sveberg (2022). Genotyping av pasienter behandlet med selektive serotoninreopptakshemmere. 9 s. Tidsskrift for Den norske legeforening. Vol. 142.
https://doi.org/10.4045/tidsskr.22.0017

Tveito, Marit; Høiseth, Gudrun; Haslemo, Tore ; Molden, Espen; Smith, Robert Løvsletten (2021). Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations—an observational study using blood samples from 1223 patients. European Journal of Clinical Pharmacology. Vol. 77.
https://doi.org/10.1007/s00228-021-03114-z

Hole, Kristine ; Arnestad, Marianne; Molden, Espen; Haslemo, Tore (2021). Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients with Depression. 4 s. Journal of Clinical Psychopharmacology. Vol. 41.
https://doi.org/10.1097/JCP.0000000000001387

Bråten, Line Skute; Haslemo, Tore ; Jukić, Marin M.; Ivanov, Maxim; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne K. (2021). A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram. Clinical Pharmacology and Therapeutics. Vol. 110.
https://doi.org/10.1002/cpt.2233

Kringen, Marianne K. ; Bråten, Line Skute; Haslemo, Tore ; Molden, Espen (2020). The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O -Desmethylvenlafaxine Concentrations in a Large Patient Cohort. 7 s. Journal of Clinical Psychopharmacology. Vol. 40.
https://doi.org/10.1097/JCP.0000000000001174

Smith, Robert Løvsletten; Kyllesø, Lennart; Haslemo, Tore ; Andreassen, Ole Andreas; Molden, Espen (2019). Reduction in N-desmethylclozapine level is determined by daily dose but not serum concentration of valproic acid-indications of a presystemic interaction mechanism. Therapeutic Drug Monitoring. Vol. 41.
https://doi.org/10.1097/FTD.0000000000000619

Forskningsrapporter

Haslemo, Tore ; Refsum, Helge; Molden, Espen (2012). Pharmacokinetic Variability of Olanzapine – A Study Based on Therapeutic Drug Monitoring Data. 96 s. Universitetet i Oslo.

Formidling

Dietrichs, Erik Sveberg; Molden, Espen; Haslemo, Tore (2022). Senter for psykofarmakologi. 3 s. LVS-info.

Dietrichs, Erik Sveberg; Solhaug, Vigdis; Haslemo, Tore ; Kringen, Marianne K. ; Molden, Espen (2022). E.S. Dietrichs og medarbeidere svarer. Tidsskrift for Den norske legeforening. Vol. 142.
https://doi.org/10.4045/tidsskr.22.0695

Dietrichs, Erik Sveberg; Solhaug, Vigdis; Kringen, Marianne Kristiansen ; Haslemo, Tore ; Molden, Espen (2022). E. S. Dietrichs og medarbeidere svarer P. Gjerden. Tidsskrift for Den norske legeforening.

Dietrichs, Erik Sveberg; Haslemo, Tore ; Kringen, Marianne K. ; Molden, Espen; Solhaug, Vigdis (2022). E. S. Dietrichs og medarbeidere svarer. Tidsskrift for Den norske legeforening. Vol. 142.
https://doi.org/10.4045/tidsskr.22.0665

Landmark, Cecilie Johannessen ; Baftiu, Arton; Haslemo, Tore (2018). Identification and handing of pharmacokinetic interactions of antiepileptic- and psychoactive drugs. 18th international congress of IATDMCT. international association of therapeutic drug monitoring and.

Gjestad, Caroline; Haslemo, Tore ; Andreassen, Ole Andreas; Molden, Espen (2018). Gjestad et al. reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker. British Journal of Clinical Pharmacology. Vol. 84.
https://doi.org/10.1111/bcp.13606

Haslemo, Tore ; Baftiu, Arton; Gottås, André; Burns, Margrete Larsen; Landmark, Cecilie Johannessen (2017). Pharmacokinetic drug interactions with valproate and antiepileptic or antipsychotic drugs – still a mystery after 50 years?. 15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology,.

Solberg, Dag Kristen; Haslemo, Tore ; Refsum, Helge (2012). Psykofarmakologisk poliklinikk. 3 s. Tidsskrift for Den norske legeforening. Vol. 132.
https://doi.org/10.4045/tidsskr.12.0130